Just Group, which is part of the FTSE 250, has agreed to be bought by Canadian asset manager Brookfield Wealth Solutions in a ...

The London Stock Exchange lost yet another constituent to foreign ownership on Thursday, after Just Group agreed to a bumper ...

A class of 9 and 10-year-olds from Trumpington Park Primary School pupils were the first to go on a Cambridge Biomedical ...

LSEG CEO David Schwimmer said the first half of the year was “marked by a consistent cadence of new product launches." ...

AstraZeneca (($AZN)) has held its Q2 earnings call. Read on for the main highlights of the call. AstraZeneca’s recent earnings call showcased a ...

Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.

Ionis Pharmaceuticals IONS reported second-quarter 2025 adjusted earnings per share (EPS) of 86 cents, significantly beating the Zacks Consensus Estimate of 27 cents. In the year-ago period, the ...

It’s 31 July, marking the official close of the June quarterly reporting period under ASX Listing Rules. For healthcare ...

Cancer clinical trials in the UK are at a critical juncture. They face significant systemic pressures within the NHS and regulatory pathways that threaten efficiency and timeliness. Both commercial ...

The Tempus AI class action lawsuit further alleges that on May 28, 2025, Spruce Point Capital Management, LLC issued research ...

Novo Nordisk promoted Maziar Mike Doustdar to president and CEO, effective August 7. The Food and Drug Administration tapped newly appointed George Tidmarsh as acting Center for Biologics Evaluation ...

President Trump on Wednesday announced a trade deal with South Korea. The agreement includes a 15% tariff rate on imports ...